Company · CIK 0001348911
KalVista Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SCHEDULE 13G/AKalVista Pharmaceuticals, Inc.0001231919-26-000933 · 17.3 KBSEC(opens sec.gov)
- SCHEDULE 13G/AKalVista Pharmaceuticals, Inc.0001214659-26-010418 · 13.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/AKalVista Pharmaceuticals, Inc.0001104659-26-096807 · 8.5 KBSEC(opens sec.gov)
- SCHEDULE 13GKalVista Pharmaceuticals, Inc.0001104659-26-093853 · 8.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-26-024949 · 381.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-26-223976 · 6.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001140361-26-017656 · 1.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-26-122784 · 189.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-26-007801 · 2.5 MBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-25-274442 · 8.3 MBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
200 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702
mailing
200 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702
Former names
- Carbylan Therapeutics, Inc.2016-11-21
- Carbylan Biosurgery, Inc2013-01-03
- Carbylan Biosurgery Inc2005-12-29
Same industry